Skip to main content
Top
Published in: Trials 1/2020

Open Access 01-12-2020 | Review

Defining key design elements of registry-based randomised controlled trials: a scoping review

Authors: Bill Karanatsios, Khic-Houy Prang, Ebony Verbunt, Justin M. Yeung, Margaret Kelaher, Peter Gibbs

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Traditional randomised controlled trials remain the gold standard for improving clinical care but they do have their limitations, including their associated high costs, high failure rate and limited external validity. An alternative methodology is the newly defined, prospective, registry-based randomised controlled trial (RRCT), where treatment and outcome data is collected in an existing registry. This scoping review explores the current literature regarding RRCTs to help identify the key design elements of RRCTs and the characteristics of clinical registries on which they are reliant on.

Methods

A scoping review methodology conducted in accordance with the Joanna Briggs Institute guidelines was performed. Four databases were searched for articles published from inception to June 2018: Medline; Embase; the Cumulative Index to Nursing and Allied Health Literature and; Scopus. The search strategy included MeSH and text words related to RRCT.

Results

We identified 2369 articles of which 75 were selected for full-text screening. Of these, only 17 articles satisfied our inclusion criteria. All studies were published between 1996 and 2017 and all were investigator-initiated. Study designs were mainly multi-site comparative/effectiveness studies incorporating the use of disease registries (n = 8), procedure registries (n = 8) and a health services registry (n = 1). The low cost, reduced administrative burden and enhanced external validity of RRCTs make them an attractive research methodology which can be used to address questions of public health importance. We identified that that there are variable definitions of what constituted a RRCT and that issues related to ethical conduct and data integrity, completeness, timeliness, validation and endpoint adjudication need to be carefully addressed.

Conclusion

RRCTs potentially have an important role to play in informing best clinical practice and health policy. There are a number of issues that need to be addressed to optimise the utility of this approach, including establishing universally accepted criteria for the definition of a RRCT.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fitzpatrick T, Perrier L, Tricco AC, Straus SE, Juni P, Zwarenstein M, et al. Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data. BMJ Open. 2017;7(2):e013770.CrossRef Fitzpatrick T, Perrier L, Tricco AC, Straus SE, Juni P, Zwarenstein M, et al. Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data. BMJ Open. 2017;7(2):e013770.CrossRef
2.
go back to reference Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, et al. Registry-based randomized controlled trials—what are the advantages, challenges, and areas for future research? J Clin Epidemiol. 2016;80:16–24.CrossRef Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, et al. Registry-based randomized controlled trials—what are the advantages, challenges, and areas for future research? J Clin Epidemiol. 2016;80:16–24.CrossRef
3.
go back to reference Bergqvist D, Bjorck M, Sawe J, Troeng T. Randomized trials or population-based registries. Eur J Vasc Endovasc Surg. 2007;34(3):253–6.CrossRef Bergqvist D, Bjorck M, Sawe J, Troeng T. Randomized trials or population-based registries. Eur J Vasc Endovasc Surg. 2007;34(3):253–6.CrossRef
4.
go back to reference Califf RM, Sugarman J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clin Trials. 2015;12(5):436–41.CrossRef Califf RM, Sugarman J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clin Trials. 2015;12(5):436–41.CrossRef
5.
go back to reference Barnish MS, Turner S. The value of pragmatic and observational studies in health care and public health. Pragmatic Observational Res. 2017;8:49–55.CrossRef Barnish MS, Turner S. The value of pragmatic and observational studies in health care and public health. Pragmatic Observational Res. 2017;8:49–55.CrossRef
6.
go back to reference Erlinge D, Omerovic E, Frobert O, Linder R, Danielewicz M, Hamid M, et al. Bivalirudin versus heparin monotherapy in myocardial infarction. N Engl J Med. 2017;377(12):1132–42.CrossRef Erlinge D, Omerovic E, Frobert O, Linder R, Danielewicz M, Hamid M, et al. Bivalirudin versus heparin monotherapy in myocardial infarction. N Engl J Med. 2017;377(12):1132–42.CrossRef
7.
go back to reference Concannon TW, Guise J-M, Dolor RJ, Meissner P, Tunis S, Krishnan JA, et al. A national strategy to develop pragmatic clinical trials infrastructure. CTS Journal. 2014;7(2):164–71. Concannon TW, Guise J-M, Dolor RJ, Meissner P, Tunis S, Krishnan JA, et al. A national strategy to develop pragmatic clinical trials infrastructure. CTS Journal. 2014;7(2):164–71.
8.
go back to reference Mathes T, Buehn S, Prengel P, Pieper D. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials. J Clin Epidemiol. 2018;93:120–7.CrossRef Mathes T, Buehn S, Prengel P, Pieper D. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials. J Clin Epidemiol. 2018;93:120–7.CrossRef
9.
go back to reference Mc Cord KA, Al-Shahi Salman R, Treweek S, Gardner H, Strech D, Whiteley W, et al. Routinely collected data for randomized trials: promises, barriers, and implications. Trials [Electronic Resource]. 2018;19(1):29. Mc Cord KA, Al-Shahi Salman R, Treweek S, Gardner H, Strech D, Whiteley W, et al. Routinely collected data for randomized trials: promises, barriers, and implications. Trials [Electronic Resource]. 2018;19(1):29.
10.
go back to reference James S, Frobert O, Lagerqvist B. Cardiovascular registries: a novel platform for randomised clinical trials. Heart. 2012;98(18):1329–31.CrossRef James S, Frobert O, Lagerqvist B. Cardiovascular registries: a novel platform for randomised clinical trials. Heart. 2012;98(18):1329–31.CrossRef
11.
go back to reference Jones WS, Roe MT, Antman EM, Pletcher MJ, Harrington RA, Rothman RL, et al. The changing landscape of randomized clinical trials in cardiovascular disease. J Am Coll Cardiol. 2016;68(17):1898–907.CrossRef Jones WS, Roe MT, Antman EM, Pletcher MJ, Harrington RA, Rothman RL, et al. The changing landscape of randomized clinical trials in cardiovascular disease. J Am Coll Cardiol. 2016;68(17):1898–907.CrossRef
12.
go back to reference Gliklich RE, Dreyer NA, Leavy MB. Registries for evaluating patient outcomes: a user’s guide. 3rd ed. Rockville: Agency for Healthcare Research and Quality; 2014. Gliklich RE, Dreyer NA, Leavy MB. Registries for evaluating patient outcomes: a user’s guide. 3rd ed. Rockville: Agency for Healthcare Research and Quality; 2014.
13.
go back to reference Meinecke AK, Welsing P, Kafatos G, Burke D, Trelle S, Kubin M, et al. Series: pragmatic trials and real world evidence: Paper 8. Data collection and management. J Clin Epidemiol. 2017;91:13–22.CrossRef Meinecke AK, Welsing P, Kafatos G, Burke D, Trelle S, Kubin M, et al. Series: pragmatic trials and real world evidence: Paper 8. Data collection and management. J Clin Epidemiol. 2017;91:13–22.CrossRef
14.
go back to reference Liu JB, D’Angelica MI, Ko CY. The Randomized Registry Trial: Two Birds, One Stone. Ann Surg. 2017;265(6):1064–5.CrossRef Liu JB, D’Angelica MI, Ko CY. The Randomized Registry Trial: Two Birds, One Stone. Ann Surg. 2017;265(6):1064–5.CrossRef
16.
go back to reference Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587–97.CrossRef Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587–97.CrossRef
17.
go back to reference Rao SV, Hess CN, Barham B, Aberle LH, Anstrom KJ, Patel TB, et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014;7(8):857–67.CrossRef Rao SV, Hess CN, Barham B, Aberle LH, Anstrom KJ, Patel TB, et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014;7(8):857–67.CrossRef
18.
go back to reference Lauer MS, D’Agostino RB. The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research? N Engl J Med. 2013;369(17):1579–81.CrossRef Lauer MS, D’Agostino RB. The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research? N Engl J Med. 2013;369(17):1579–81.CrossRef
19.
20.
go back to reference The Joanna Briggs Institute. The Joanna Briggs Institute reviewers' manual 2015: Methodology for JBI scoping reviews. 2015. The Joanna Briggs Institute. The Joanna Briggs Institute reviewers' manual 2015: Methodology for JBI scoping reviews. 2015.
21.
go back to reference Tricco ACea. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):7.CrossRef Tricco ACea. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):7.CrossRef
22.
go back to reference Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.CrossRef Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.CrossRef
23.
go back to reference Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, et al. Randomized Comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention. The SORT OUT VII Trial. Circ Cardiovasc Interv. 2016;9(7):e003610. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003610. Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, et al. Randomized Comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention. The SORT OUT VII Trial. Circ Cardiovasc Interv. 2016;9(7):e003610. https://​doi.​org/​10.​1161/​CIRCINTERVENTION​S.​115.​003610.
24.
go back to reference Lagerqvist B, Frobert O, Olivecrona GK, Gudnason T, Maeng M, Alstrom P, et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med. 2014;371(12):1111–20.CrossRef Lagerqvist B, Frobert O, Olivecrona GK, Gudnason T, Maeng M, Alstrom P, et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med. 2014;371(12):1111–20.CrossRef
25.
go back to reference Kristensen B, Ejlertsen B, Mouridsen HT, Andersen KW, Lauritzen JB. Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Res Treat. 1996;39(3):321–6.CrossRef Kristensen B, Ejlertsen B, Mouridsen HT, Andersen KW, Lauritzen JB. Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Res Treat. 1996;39(3):321–6.CrossRef
26.
go back to reference Daley MF, Steiner JF, Brayden RM, Xu S, Morrison S, Kempe A. Immunization registry-based recall for a new vaccine. Ambul Pediatr. 2002;2(6):438–43.CrossRef Daley MF, Steiner JF, Brayden RM, Xu S, Morrison S, Kempe A. Immunization registry-based recall for a new vaccine. Ambul Pediatr. 2002;2(6):438–43.CrossRef
27.
go back to reference Dombkowski KJ, Harrington LB, Dong S, Clark SJ. Seasonal influenza vaccination reminders for children with high-risk conditions: a registry-based randomized trial. Am J Prev Med. 2012;42(1):71–5.CrossRef Dombkowski KJ, Harrington LB, Dong S, Clark SJ. Seasonal influenza vaccination reminders for children with high-risk conditions: a registry-based randomized trial. Am J Prev Med. 2012;42(1):71–5.CrossRef
28.
go back to reference Dombkowski KJ, Costello LE, Harrington LB, Dong S, Kolasa M, Clark SJ. Age-specific strategies for immunization reminders and recalls: a registry-based randomized trial. Am J Prev Med. 2014;47(1):1–8.CrossRef Dombkowski KJ, Costello LE, Harrington LB, Dong S, Kolasa M, Clark SJ. Age-specific strategies for immunization reminders and recalls: a registry-based randomized trial. Am J Prev Med. 2014;47(1):1–8.CrossRef
29.
go back to reference Kempe A, Daley MF, Barrow J, Allred N, Hester N, Beaty BL, et al. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics. 2005;115(1):146–54.CrossRef Kempe A, Daley MF, Barrow J, Allred N, Hester N, Beaty BL, et al. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics. 2005;115(1):146–54.CrossRef
30.
go back to reference LeBaron CW, Starnes DM, Rask KJ. The impact of reminder-recall interventions on low vaccination coverage in an inner-city population. Arch Pediatr Adolesc Med. 2004;158(3):255–61.CrossRef LeBaron CW, Starnes DM, Rask KJ. The impact of reminder-recall interventions on low vaccination coverage in an inner-city population. Arch Pediatr Adolesc Med. 2004;158(3):255–61.CrossRef
31.
go back to reference Irigoyen MM, Findley S, Wang D, Chen S, Chimkin F, Pena O, et al. Challenges and successes of immunization registry reminders at inner-city practices. Ambul Pediatr. 2006;6(2):100–4.CrossRef Irigoyen MM, Findley S, Wang D, Chen S, Chimkin F, Pena O, et al. Challenges and successes of immunization registry reminders at inner-city practices. Ambul Pediatr. 2006;6(2):100–4.CrossRef
32.
go back to reference Hall AE, Sanson-Fisher RW, Lynagh MC, Threlfall T, D’Este CA. Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial. J Clin Epidemiol. 2013;66(1):85–94.CrossRef Hall AE, Sanson-Fisher RW, Lynagh MC, Threlfall T, D’Este CA. Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial. J Clin Epidemiol. 2013;66(1):85–94.CrossRef
33.
go back to reference Barbanti M, Gulino S, Capranzano P, Imme S, Sgroi C, Tamburino C, et al. Acute kidney injury with the RenalGuard system in patients undergoing transcatheter aortic valve replacement. The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv. 2015;8(12):1595–604.CrossRef Barbanti M, Gulino S, Capranzano P, Imme S, Sgroi C, Tamburino C, et al. Acute kidney injury with the RenalGuard system in patients undergoing transcatheter aortic valve replacement. The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv. 2015;8(12):1595–604.CrossRef
34.
go back to reference van der Veer SN, de Vos ML, van der Voort PH, Peek N, Abu-Hanna A, Westert GP, et al. Effect of a multifaceted performance feedback strategy on length of stay compared with benchmark reports alone: a cluster randomized trial in intensive care. Crit Care Med. 2013;41(8):1893–904.CrossRef van der Veer SN, de Vos ML, van der Voort PH, Peek N, Abu-Hanna A, Westert GP, et al. Effect of a multifaceted performance feedback strategy on length of stay compared with benchmark reports alone: a cluster randomized trial in intensive care. Crit Care Med. 2013;41(8):1893–904.CrossRef
35.
go back to reference Alexander KP, Wang TY, Li S, Lytle BL, Slattery LE, Calhoun S, et al. Randomized trial of targeted performance feedback to facilitate quality improvement. Circ Cardiovasc Qual Outcomes. 2011;4(1):129–35.CrossRef Alexander KP, Wang TY, Li S, Lytle BL, Slattery LE, Calhoun S, et al. Randomized trial of targeted performance feedback to facilitate quality improvement. Circ Cardiovasc Qual Outcomes. 2011;4(1):129–35.CrossRef
36.
go back to reference Hofmann R, James SK, Jernberg T, Lindahl B, Erlinge D, Witt N, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377(13):1240–9.CrossRef Hofmann R, James SK, Jernberg T, Lindahl B, Erlinge D, Witt N, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377(13):1240–9.CrossRef
37.
go back to reference Ieva F, Gale CP, Sharples LD. Contemporary roles of registries in clinical cardiology: when do we need randomized trials? Expert Rev Cardiovasc Ther. 2014;12(12):1383–6.CrossRef Ieva F, Gale CP, Sharples LD. Contemporary roles of registries in clinical cardiology: when do we need randomized trials? Expert Rev Cardiovasc Ther. 2014;12(12):1383–6.CrossRef
38.
go back to reference James S, Rao S, Granger C. Registry-based randomized clinical trials— A new clinical trial paradigm. Nat Rev Cardiol. 2015;12(5):312–6.CrossRef James S, Rao S, Granger C. Registry-based randomized clinical trials— A new clinical trial paradigm. Nat Rev Cardiol. 2015;12(5):312–6.CrossRef
40.
go back to reference Ashrafi R, Hussain H, Brisk R, Boardman L, Weston C. Clinical disease registries in acute myocardial infarction. World J Cardiol. 2014;6(6):415–23.CrossRef Ashrafi R, Hussain H, Brisk R, Boardman L, Weston C. Clinical disease registries in acute myocardial infarction. World J Cardiol. 2014;6(6):415–23.CrossRef
41.
go back to reference Kwakkenbos L, Juszczak E, Hemkens LG, Sampson M, Fröbert O, Relton C, et al. Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data. Res Integrity Peer Rev. 2018;3(1):9.CrossRef Kwakkenbos L, Juszczak E, Hemkens LG, Sampson M, Fröbert O, Relton C, et al. Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data. Res Integrity Peer Rev. 2018;3(1):9.CrossRef
42.
go back to reference Schmidt M, Maeng M, Jakobsen C-J, Madsen M, Thuesen L, Nielsen PH, et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol. 2010;2:137.CrossRef Schmidt M, Maeng M, Jakobsen C-J, Madsen M, Thuesen L, Nielsen PH, et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol. 2010;2:137.CrossRef
43.
go back to reference Christiansen P, Ejlertsen B, Jensen M-B, Mouridsen H. Danish Breast Cancer Cooperative Group. Clin Epidemiol. 2016;8:445.CrossRef Christiansen P, Ejlertsen B, Jensen M-B, Mouridsen H. Danish Breast Cancer Cooperative Group. Clin Epidemiol. 2016;8:445.CrossRef
44.
go back to reference Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012;60(20):2017–31.CrossRef Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012;60(20):2017–31.CrossRef
Metadata
Title
Defining key design elements of registry-based randomised controlled trials: a scoping review
Authors
Bill Karanatsios
Khic-Houy Prang
Ebony Verbunt
Justin M. Yeung
Margaret Kelaher
Peter Gibbs
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04459-z

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue